InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Perspective Therapeutics, Inc.

CATX Clue Score36
United States Fiscal year ends December CIK 0000728387 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Mark John Austin
23 Apr 2024
VP Finance/Prin Fin&Acct Offic
Exercised, kept
30,000
$0.36
$10.80K
Lori A Woods
17 Apr 2023
Director
Exercised, kept indirect
23,566
$0.61
$14.38K
Lori A Woods
13 Apr 2023
Director
Exercised, kept indirect
163,934
$0.61
$100.00K
Jennifer Streeter
18 Aug 2022
COO & VP of HR
Exercised, kept
50,000
$0.43
$21.50K
Jennifer Streeter
5 Aug 2022
COO & VP of HR
Exercised, kept
22,500
$0.33
$7.43K
Lori A Woods
23 Nov 2021
CEO
Exercised, kept indirect
62,500
$0.43
$26.88K
Lori A Woods
23 Nov 2021
CEO
Exercised, kept indirect
62,500
$0.46
$28.75K
Lori A Woods
12 Mar 2021
CEO
Exercised, kept indirect
24,038
$0.57
$13.70K
Lori A Woods
12 Mar 2021
CEO
Exercised, kept indirect
62,500
$0.61
$38.13K
Lori A Woods
12 Mar 2021
CEO
Exercised, kept indirect
62,500
$0.43
$26.88K
Lori A Woods
12 Mar 2021
CEO
Exercised, kept indirect
62,500
$0.46
$28.75K
Lori A Woods
12 Mar 2021
CEO
Exercised, kept indirect
25,000
$0.61
$15.13K
Lori A Woods
3 Feb 2020
CEO
Exercised, kept indirect
62,500
$0.43
$26.88K
Lori A Woods
3 Feb 2020
CEO
Exercised, kept indirect
125,000
$0.46
$57.50K
Lori A Woods
3 Feb 2020
CEO
Exercised, kept indirect
75,000
$0.61
$45.38K
Krista Cline
30 May 2019
Dir. of Operations, Secretary
Exercised, kept
21,900
$0.26
$5.69K
Thomas C Lavoy
20 Nov 2017
CEO and Chairman of the Board
Exercised, kept
82,810
$0.61
$50.10K
Show all 152 transactions →

What was left out

Form 4 filings counted 168
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 1,018,748
History held since 26 Oct 2006